Larger Than Life Science is a free monthly event series open to everyone interested in building a strong support network for biotech, life science, and healthcare innovators.
Due to public health concerns related to COVID-19, Larger Than Life Science is going virtual. For the first time ever you can join LaunchBio from anywhere in the world to experience programming for life science entrepreneurs. Webinars will be live-streaming free on Zoom and made available on LaunchBio’s website following the program.
This month’s theme: Thinking Ahead: Our Regenerative Future
Stem cells hold the potential to cure a wide range of diseases and researchers have dreamed of using them to repair damaged tissue, fight neurological problems and even create new organs. But such medical uses have attracted controversy and proven tricky both in the lab and with regulatory agencies. Join LaunchBio this month to explore a new decade of opportunities with regenerative medicine.
Panel: Promise & Possibility: Current State of Stem Cell Medicine
The global regenerative medicine market is expected to reach $5.6 billion by 2025. Due to its wide range of applications regenerative medicine will continue to gain traction both within research institutions and with investors looking to ride the wave. But what can we expect in the next 10-years? What areas hold the most promise and who is receiving the funding? Join this panel of experts to explore the promise and possibilities of our regenerative future.
Speakers:
- Matt Bresnahan, Partner, Wilson Sonsini
- Samuel Chuang, PhD, Director, Scientific Advisory Services at Charles River Laboratories
- Westbrook Weaver, PhD, Founder and Chief Executive Officer, Tempo Therapeutics Inc.
- Karen Christman, PhD, Professor, Bioengineering, UC San Diego